TotalMarketCap

Spruce Biosciences

SPRBNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$122.375 M

$42.58 -8.65%

Close of 6 Nov 2026

As of 6 Nov 2026, Spruce Biosciences (SPRB) has a market capitalization of $122.4M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$0.00

#3616 by revenue

Earnings

-$39.0M

Loss-making

Shares outstanding

2,874,013

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #275Yarrow BioscienceYARW$126.1M
  2. #276PDS BiotechnologyPDSB$123.9M
  3. #277Spruce BiosciencesSPRB$122.4M
  4. #278Akebia TherapeuticsAKBA$121.3M
  5. #279Journey MedicalDERM$121.2M

What if Spruce Biosciences were worth as much as…

Open the what-if tool →

Gold $28.2T

$9,824,894

Per share 230,740× higher

Bitcoin $1.53T

$531,607.92

Per share 12,485× higher

Apple $5.02T

$1,745,219

Per share 40,987× higher

Or at a round number

$200.0M$500.0M$1.00B$2.00B

Where these numbers come from

Share counts and financials for Spruce Biosciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.